Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Stem Cell Research

Free Subscription Articles published in Oncogene Retrieve available abstracts of 78 articles: HTML format Text format

Single Articles

April 2019
1. HU J, Mirshahidi S, Simental A, Lee SC, et al
   Cancer stem cell self-renewal as a therapeutic target in human oral cancer.
   Oncogene. 2019 Apr 1. pii: 10.1038/s41388-019-0800.
   PubMed     Text format     Abstract available
   
   
   
2. NISHIMURA T, Nakata A, Chen X, Nishi K, et al
   Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
   Oncogene. 2019;38:2464-2481.
   PubMed     Text format     Abstract available
   
   
   March 2019
3. WU M, Sheng L, Cheng M, Zhang H, et al
   Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells.
   Oncogene. 2019 Mar 27. pii: 10.1038/s41388-019-0799.
   PubMed     Text format     Abstract available
   
   
   
4. WANG L, Zhang Z, Yu X, Huang X, et al
   Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma.
   Oncogene. 2019;38:2042-2055.
   PubMed     Text format     Abstract available
   
   
   February 2019
5. MUNOZ-GALVAN S, Lucena-Cacace A, Perez M, Otero-Albiol D, et al
   Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.
   Oncogene. 2019;38:1309-1323.
   PubMed     Text format     Abstract available
   
   
   
6. ARIMA K, Ohmuraya M, Miyake K, Koiwa M, et al
   Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
   Oncogene. 2019;38:1211-1224.
   PubMed     Text format     Abstract available
   
   
   January 2019
7. CASTAGNOLI L, Cancila V, Cordoba-Romero SL, Faraci S, et al
   WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
   Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0700.
   PubMed     Text format     Abstract available
   
   
   
8. WOOSLEY AN, Dalton AC, Hussey GS, Howley BV, et al
   TGFbeta promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
   Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0703.
   PubMed     Text format     Abstract available
   
   
   
9. ZHOU H, Yu C, Kong L, Xu X, et al
   B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
   Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0674.
   PubMed     Text format     Abstract available
   
   
   
10. DOMENICI G, Aurrekoetxea-Rodriguez I, Simoes BM, Rabano M, et al
    A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0656.
    PubMed     Text format     Abstract available
    
    
    
11. GOLD A, Eini L, Nissim-Rafinia M, Viner R, et al
    Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0654.
    PubMed     Text format     Abstract available
    
    
    
12. LAU BW, Huh K, Madero-Marroquin R, De Marchi F, et al
    Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity.
    Oncogene. 2019;38:687-698.
    PubMed     Text format     Abstract available
    
    
    
13. CHEN-WICHMANN L, Shvartsman M, Preiss C, Hockings C, et al
    Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.
    Oncogene. 2019;38:261-272.
    PubMed     Text format     Abstract available
    
    
    
14. PATEL Y, Soni M, Awgulewitsch A, Kern MJ, et al
    Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Oncogene. 2019;38:445-453.
    PubMed     Text format     Abstract available
    
    
    
15. BAO Y, Guo Y, Yang Y, Wei X, et al
    PRSS8 suppresses colorectal carcinogenesis and metastasis.
    Oncogene. 2019;38:497-517.
    PubMed     Text format     Abstract available
    
    
    
16. WENG CH, Chen LY, Lin YC, Shih JY, et al
    Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI.
    Oncogene. 2019;38:455-468.
    PubMed     Text format     Abstract available
    
    
    December 2018
17. LIU S, Yin P, Kujawa SA, Coon JS 5th, et al
    Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0612.
    PubMed     Text format     Abstract available
    
    
    
18. HE Y, Hooker E, Yu EJ, Cunha GR, et al
    Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
    Oncogene. 2018 Dec 3. pii: 10.1038/s41388-018-0583.
    PubMed     Text format     Abstract available
    
    
    
19. OHNO Y, Shingyoku S, Miyake S, Tanaka A, et al
    Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
    Oncogene. 2018;37:6357-6367.
    PubMed     Text format     Abstract available
    
    
    November 2018
20. WENG CC, Ding PY, Liu YH, Hawse JR, et al
    Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.
    Oncogene. 2018 Nov 22. pii: 10.1038/s41388-018-0575.
    PubMed     Text format     Abstract available
    
    
    
21. AN J, Du Y, Fan X, Wang Y, et al
    EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    Oncogene. 2018 Nov 19. pii: 10.1038/s41388-018-0565.
    PubMed     Text format     Abstract available
    
    
    
22. KUMAR S, Srivastav RK, Wilkes DW, Ross T, et al
    Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0562.
    PubMed     Text format     Abstract available
    
    
    
23. HU YB, Yan C, Mu L, Mi YL, et al
    Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
    Oncogene. 2018 Nov 2. pii: 10.1038/s41388-018-0557.
    PubMed     Text format     Abstract available
    
    
    
24. OOKI A, Dinalankara W, Marchionni L, Tsay JJ, et al
    Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
    Oncogene. 2018;37:5967-5981.
    PubMed     Text format     Abstract available
    
    
    October 2018
25. ZEPECKI JP, Snyder KM, Moreno MM, Fajardo E, et al
    Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor.
    Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0546.
    PubMed     Text format     Abstract available
    
    
    
26. BAKHSHINYAN D, Venugopal C, Adile AA, Garg N, et al
    BMI1 is a therapeutic target in recurrent medulloblastoma.
    Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0549.
    PubMed     Text format     Abstract available
    
    
    
27. SHIMIZU M, Tanaka N
    IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0533.
    PubMed     Text format     Abstract available
    
    
    
28. LI B, Xu H, Han H, Song S, et al
    Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis.
    Oncogene. 2018;37:5508-5519.
    PubMed     Text format     Abstract available
    
    
    September 2018
29. PAI VC, Hsu CC, Chan TS, Liao WY, et al
    ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling.
    Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0497.
    PubMed     Text format     Abstract available
    
    
    
30. BALAMURUGAN K, Mendoza-Villanueva D, Sharan S, Summers GH, et al
    C/EBPdelta links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0516.
    PubMed     Text format     Abstract available
    
    
    
31. CHEN T, Chen J, Zhu Y, Li Y, et al
    CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
    Oncogene. 2018 Sep 26. pii: 10.1038/s41388-018-0515.
    PubMed     Text format     Abstract available
    
    
    
32. NAKANO M, Kikushige Y, Miyawaki K, Kunisaki Y, et al
    Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.
    Oncogene. 2018 Sep 4. pii: 10.1038/s41388-018-0480.
    PubMed     Text format     Abstract available
    
    
    
33. GOTO H, Shimono Y, Funakoshi Y, Imamura Y, et al
    Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0477.
    PubMed     Text format     Abstract available
    
    
    August 2018
34. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0472.
    PubMed     Text format     Abstract available
    
    
    
35. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
    Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0445.
    PubMed     Text format     Abstract available
    
    
    
36. TOSHIYAMA R, Konno M, Eguchi H, Takemoto H, et al
    Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
    Oncogene. 2018 Aug 8. pii: 10.1038/s41388-018-0406.
    PubMed     Text format     Abstract available
    
    
    
37. LIU Z, Zhang W, Phillips JB, Arora R, et al
    Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0407.
    PubMed     Text format     Abstract available
    
    
    
38. MAURIZI G, Verma N, Gadi A, Mansukhani A, et al
    Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma.
    Oncogene. 2018;37:4626-4632.
    PubMed     Text format     Abstract available
    
    
    
39. HANDLER J, Cullis J, Avanzi A, Vucic EA, et al
    Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-beta exposure.
    Oncogene. 2018;37:4334-4342.
    PubMed     Text format     Abstract available
    
    
    July 2018
40. LU CH, Yeh DW, Lai CY, Liu YL, et al
    USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0411.
    PubMed     Text format     Abstract available
    
    
    
41. SHI L, Tang X, Qian M, Liu Z, et al
    A SIRT1-centered circuitry regulates breast cancer stemness and metastasis.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0370.
    PubMed     Text format     Abstract available
    
    
    
42. LUO L, Tang H, Ling L, Li N, et al
    LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Oncogene. 2018 Jul 12. pii: 10.1038/s41388-018-0396.
    PubMed     Text format     Abstract available
    
    
    
43. JI C, Yang L, Yi W, Xiang D, et al
    Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/beta-catenin pathway.
    Oncogene. 2018;37:3953-3966.
    PubMed     Text format     Abstract available
    
    
    
44. ZIMMERLI D, Cecconi V, Valenta T, Hausmann G, et al
    WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
    Oncogene. 2018;37:3753-3762.
    PubMed     Text format     Abstract available
    
    
    May 2018
45. LIAO CP, Lin TP, Li PC, Geary LA, et al
    Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0325.
    PubMed     Text format     Abstract available
    
    
    
46. GABBASOV R, Xiao F, Howe CG, Bickel LE, et al
    NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0296.
    PubMed     Text format     Abstract available
    
    
    
47. GRUN D, Adhikary G, Eckert RL
    NRP-1 interacts with GIPC1 and alpha6/beta4-integrins to increase YAP1/Np63alpha-dependent epidermal cancer stem cell survival.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0290.
    PubMed     Text format     Abstract available
    
    
    
48. BAKER A, Wyatt D, Bocchetta M, Li J, et al
    Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
    PubMed     Text format     Abstract available
    
    
    
49. LI N, Zhang Y, Sidlauskas K, Ellis M, et al
    Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0277.
    PubMed     Text format     Abstract available
    
    
    
50. CHEN A, Sceneay J, Godde N, Kinwel T, et al
    Intermittent hypoxia induces a metastatic phenotype in breast cancer.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
    PubMed     Text format     Abstract available
    
    
    
51. TAKAHASHI K, Ehata S, Koinuma D, Morishita Y, et al
    Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells.
    Oncogene. 2018;37:2757-2772.
    PubMed     Text format     Abstract available
    
    
    April 2018
52. TOOSI BM, El Zawily A, Truitt L, Shannon M, et al
    EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
    Oncogene. 2018 Apr 27. pii: 10.1038/s41388-018-0228.
    PubMed     Text format     Abstract available
    
    
    March 2018
53. MONTERISI S, Riso PL, Russo K, Bertalot G, et al
    HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype.
    Oncogene. 2018 Mar 26. pii: 10.1038/s41388-018-0229.
    PubMed     Text format     Abstract available
    
    
    February 2018
54. CAJA L, Tzavlaki K, Dadras MS, Tan EJ, et al
    Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0136.
    PubMed     Text format     Abstract available
    
    
    
55. MANCINI R, Noto A, Pisanu ME, De Vitis C, et al
    Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
    Oncogene. 2018 Feb 15. pii: 10.1038/s41388-018-0141.
    PubMed     Text format     Abstract available
    
    
    
56. IDOUX-GILLET Y, Nassour M, Lakis E, Bonini F, et al
    Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.
    Oncogene. 2018;37:578-588.
    PubMed     Text format     Abstract available
    
    
    January 2018
57. AKHTER MZ, Sharawat SK, Kumar V, Kochat V, et al
    Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM(+)CD45(+) phenotype.
    Oncogene. 2018 Jan 30. pii: 10.1038/s41388-017-0106.
    PubMed     Text format     Abstract available
    
    
    
58. O'BRIEN KP, Khan S, Gilligan KE, Zafar H, et al
    Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0116.
    PubMed     Text format     Abstract available
    
    
    
59. SOLOMON H, Dinowitz N, Pateras IS, Cooks T, et al
    Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0060.
    PubMed     Text format     Abstract available
    
    
    December 2017
60. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    November 2017
61. ALMIRON BONNIN DA, Havrda MC, Lee MC, Liu H, et al
    Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
    Oncogene. 2017 Nov 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
62. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    October 2017
63. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
    Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
    Oncogene. 2017;36:6020-6029.
    PubMed     Text format     Abstract available
    
    
    
64. OTANI Y, Ichikawa T, Kurozumi K, Inoue S, et al
    Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
65. SIZEMORE GM, Balakrishnan S, Hammer AM, Thies KA, et al
    Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
    Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
66. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
    Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
67. WANG CH, Wang PJ, Hsieh YC, Lo S, et al
    Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    September 2017
68. YOUN H, Lee HK, Sohn HR, Park UH, et al
    RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
69. WANG F, Wang AY, Chesnelong C, Yang Y, et al
    ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
70. DEBRUYNE DN, Turchi L, Burel-Vandenbos F, Fareh M, et al
    DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
71. KIM M, Jang K, Miller P, Picon-Ruiz M, et al
    VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
    Oncogene. 2017;36:5199-5211.
    PubMed     Text format     Abstract available
    
    
    August 2017
72. LI XX, Zhang HS, Xu YM, Zhang RJ, et al
    Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells.
    Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
73. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    July 2017
74. FETTIG LM, McGinn O, Finlay-Schultz J, LaBarbera DV, et al
    Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
    Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
75. PISTORE C, Giannoni E, Colangelo T, Rizzo F, et al
    DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
76. SENGUPTA S, Nagalingam A, Muniraj N, Bonner MY, et al
    Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    
77. PEREZ-ALEA M, McGrail K, Sanchez-Redondo S, Ferrer B, et al
    ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    
    May 2017
78. RAJA E, Komuro A, Tanabe R, Sakai S, et al
    Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: